Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T79031 | Target Info | |||
Target Name | Beta-secretase 1 (BACE1) | ||||
Synonyms | Membrane-associated aspartic protease 2; Memapsin-2; KIAA1149; Beta-site amyloid precursor protein cleaving enzyme 1; Beta-site APP cleaving enzyme 1; BACE; Aspartyl protease 2; Asp 2; ASP2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BACE1 | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (6s)-2-Amino-6-(3'-Methoxybiphenyl-3-Yl)-3,6-Dimethyl-5,6-Dihydropyrimidin-4(3h)-One | Ligand Info | |||
Canonical SMILES | CC1(CC(=O)N(C(=N1)N)C)C2=CC=CC(=C2)C3=CC(=CC=C3)OC | ||||
InChI | 1S/C19H21N3O2/c1-19(12-17(23)22(2)18(20)21-19)15-8-4-6-13(10-15)14-7-5-9-16(11-14)24-3/h4-11H,12H2,1-3H3,(H2,20,21)/t19-/m0/s1 | ||||
InChIKey | LQOCXPOKEPYGTJ-IBGZPJMESA-N | ||||
PubChem Compound ID | 17749735 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 2VA6 X-ray crystal structure of beta secretase complexed with compound 24 | ||||||
Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | Yes | [1] |
PDB Sequence |
FVEMVDNLRG
8 KSGQGYYVEM18 TVGSPPQTLN28 ILVDTGSSNF38 AVGAAPHPFL48 HRYYQRQLSS 58 TYRDLRKGVY68 VPYTQGKWEG78 ELGTDLVSIP88 HGPNVTVRAN98 IAAITESDKF 108 FINGSNWEGI118 LGLAYAEIAR128 PDDSLEPFFD138 SLVKQTHVPN148 LFSLQLCGAS 169 VGGSMIIGGI179 DHSLYTGSLW189 YTPIRREWYY199 EVIIVRVEIN209 GQDLKMDCKE 219 YNYDKSIVDS229 GTTNLRLPKK239 VFEAAVKSIK249 AASSTEKFPD259 GFWLGEQLVC 269 WQAGTTPWNI279 FPVISLYLMG289 EVTNQSFRIT299 ILPQQYLRPV309 EDVATSQDDC 319 YKFAISQSST329 GTVMGAVIME339 GFYVVFDRAR349 KRIGFAVSAC359 HVHDEFRTAA 369 VEGPFVTLDM379 EDCGYNI
|
|||||
|
LYS9
4.202
SER10
2.930
GLY11
3.518
GLN12
3.563
GLY13
3.158
TYR14
4.750
LEU30
3.832
ASP32
2.760
GLY34
3.659
SER35
3.952
TYR71
3.497
|
|||||
PDB ID: 4FS4 Structure of BACE Bound to (S)-4-(3'-methoxy-[1,1'-biphenyl]-3-yl)-1,4-dimethyl-6-oxotetrahydropyrimidin-2(1H)-iminium | ||||||
Method | X-ray diffraction | Resolution | 1.74 Å | Mutation | No | [2] |
PDB Sequence |
GSFVEMVDNL
67 RGKSGQGYYV77 EMTVGSPPQT87 LNILVDTGSS97 NFAVGAAPHP107 FLHRYYQRQL 117 SSTYRDLRKG127 VYVPYTQGKW137 EGELGTDLVS147 IPHGPNVTVR157 ANIAAITESD 167 KFFINGSNWE177 GILGLAYAEI187 ARPDDSLEPF197 FDSLVKQTHV207 PNLFSLQLCG 217 AGFPLNQSEV227 LASVGGSMII237 GGIDHSLYTG247 SLWYTPIRRE257 WYYEVIIVRV 267 EINGQDLKMD277 CKEYNYDKSI287 VDSGTTNLRL297 PKKVFEAAVK307 SIKAASSTEK 317 FPDGFWLGEQ327 LVCWQAGTTP337 WNIFPVISLY347 LMGEVTNQSF357 RITILPQQYL 367 RPVEDVATSQ377 DDCYKFAISQ387 SSTGTVMGAV397 IMEGFYVVFD407 RARKRIGFAV 417 SACHVHDEFR427 TAAVEGPFVT437 LDMEDCGYNI447
|
|||||
|
LYS70
4.530
SER71
3.230
GLY72
3.487
GLN73
3.528
GLY74
3.447
TYR75
4.828
LEU91
3.898
ASP93
2.611
GLY95
3.922
SER96
4.276
TYR132
3.415
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency. J Med Chem. 2007 Nov 29;50(24):5912-25. | ||||
REF 2 | A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of beta-Secretase. ACS Med Chem Lett. 2012 Mar 29;3(11):886-91. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.